The Day In Review: Biotech Takes A Beating

February 9, 2005 -- Late waves of selling hit the market today, causing stocks to close near their lows. Biotech sustained a huge loss, with the Centient Biotech 200 off 101.65 points, closing at 3346.64, a very substantial 2.94% decline. We look at Inspire's uninspiring 45% drop after a Phase III trial failure, Forest Labs clot-dissolving drug derived from the venom of vampire bats, a collaboration between Metronic and Alnylam, and BioDelivery's buccal-delivered nausea and vomiting medication...